RecruitingNCT06481943

A Prospective Research Investigation of Ischemia Using MCG

A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device

Sponsor

SB Technology, Inc.

Enrollment

150 participants

Start Date

Jul 11, 2024

Study Type

OBSERVATIONAL

Conditions

Acute Coronary Syndrome

Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
Ability for participant to comply with study requirements
Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
Written informed consent

Exclusion Criteria5

Present STEMI
Pregnant or breastfeeding
Having an active atrial fibrillation episode as seen on most current 12-lead ECG
Active thoracic metal implant
Poor access to follow-up

Interested in this trial?

Get notified about updates and connect with the research team.